stockrow
Tuesday 3 November 2026
Export MOH’s income statement to Excel — free account
Molina Healthcare, Inc
MOH Healthcare Healthcare Plans
Molina Healthcare, Inc’s revenue for fiscal 2025 (year ended December 2025) was $45.4 billion, up 11.7% from fiscal 2024.
- Revenue
- −3.44%
- EPS
- −51.7%
- Free cash flow
- −20.3%
- Total debt
- +2.54%
Quarter to September 2026, against a year earlier
208.45
3.67
+1.79%
Follow MOH
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 39.44 | 20.27 |
+8 more quarters Free account |
P/S ratio |
0.22 | 0.26 | 0.15 | 0.20 | |
P/FCF ratio |
40.68 | 43.12 | 27.03 | 0.00 | |
P/Operating CF |
(60.89) | (39.75) | 6.27 | (30.75) | |
P/B ratio |
2.33 | 2.80 | 1.66 | 2.25 | |
Price to Tangible BV |
4.65 | 5.59 | 3.41 | 4.89 | |
EV/Sales |
0.12 | 0.15 | 0.03 | 0.11 | |
EV/EBITDA |
15.25 | 18.20 | 2.44 | 5.00 | |
EV/Operating CF |
15.34 | 18.49 | 4.22 | (9.13) | |
EV/FCF |
21.34 | 24.91 | 6.00 | (7.68) | |
Quick Ratio |
1.61 | 1.61 | 1.55 | 1.60 | |
Current Ratio |
1.69 | 1.68 | 1.63 | 1.69 | |
Net Debt/EBITDA |
(32.15) | (26.82) | (43.48) | 36.49 | |
Debt/Assets |
25.24% | 24.70% | 24.08% | 25.38% | |
Debt/Equity |
0.95 | 0.95 | 0.97 | 0.97 | |
Asset Turnover |
2.82 | 2.76 | 2.75 | 2.91 | |
Operating CF/Net income |
(4.18) | (4.90) | 77.29 | 1.86 | |
Capex/Depreciation |
(0.97) | (0.75) | (0.69) | 0.02 | |
Interest Coverage |
2.00 | 2.69 | 1.54 | (3.12) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
6.41% | 6.66% | 7.22% | 6.99% | |
Intangible Assets out of Total Assets |
0.13 | 0.13 | 0.13 | 0.14 | |
Share Based Compensation of Revenue |
0.23% | 0.24% | 0.31% | 0.18% | |
Graham Net Nets |
0.11 | 0.09 | 0.15 | 0.10 | |
Graham Number |
0.00 | 0.00 | 78.08 | 121.83 | |
Earnings Yield |
(0.51%) | (0.08%) | 2.54% | 4.93% | |
Free Cash Flow Yield |
2.46% | 2.32% | 3.70% | (6.94%) | |
Revenue per Share |
216.45 | 212.80 | 212.10 | 215.44 | |
Operating CF per Share |
(3.11) | (5.75) | 21.26 | (5.64) | |
Capex per Share |
(0.72) | (0.59) | (0.53) | 0.02 | |
Free Cash Flow per Share |
(3.83) | (6.34) | 20.73 | (5.62) | |
Cash per Share |
167.56 | 174.46 | 181.75 | 156.36 | |
Shareholders Equity per Share |
81.15 | 81.62 | 80.16 | 77.06 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
81.15 | 81.62 | 80.16 | 77.06 | |
Free Cash Flow |
(196.00) | (324.00) | 1,055.00 | (297.00) | |
Working Capital |
5,120.00 | 5,228.00 | 5,138.00 | 5,072.00 | |
Capital Expenditures |
(37.00) | (30.00) | (27.00) | 1.00 | |
Net Current Asset Value |
1,017.00 | 1,096.00 | 1,015.00 | 949.00 | |
EV/EBIT |
29.53 | 33.25 | 3.50 | 6.25 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Operating Income |
56.29 | 57.57 | 15.74 | 11.73 | |
| Other line items | |||||
Average Receivables |
3,437.00 | 3,675.00 | 3,455.50 | 3,416.00 | |
Average Payables |
1,153.50 | 1,126.00 | 1,140.00 | 1,212.00 | |
Average Assets |
15,675.00 | 16,106.00 | 16,388.50 | 15,597.00 | |
Average Common Equity |
4,173.00 | 4,387.00 | 4,195.00 | 4,282.50 |
Columns are period end dates · fundamentals updated 2 Nov 2026